The prognostic utility of GRACE risk score in predictive cardiovascular event rate in STEMI patients with successful fibrinolysis and delay intervention in non PCI-capable hospital: a retrospective cohort study

BACKGROUND: Fibrinolytic therapy is the main reperfusion therapy for most STEMI patients in several countries. Current practice guidelines recommended routine early pharmacoinvasive (within 3–24 h after successful fibrinolysis, however it cannot be performed in timely fashion due to limitation of PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chotechuang, Yotsawee, Phrommintikul, Arintaya, Muenpa, Roungtiva, Patumanond, Jayanton, Chaichuen, Tuanchai, Kuanprasert, Srun, Thanachikun, Noparat, Benjanuwatra, Thanawat, Sukonthasarn, Apichard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100095/
https://www.ncbi.nlm.nih.gov/pubmed/27821064
http://dx.doi.org/10.1186/s12872-016-0383-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100095/
https://www.ncbi.nlm.nih.gov/pubmed/27821064
http://dx.doi.org/10.1186/s12872-016-0383-3

Ejemplares similares